Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway - Couverture souple

Kollur, Shiva Prasad

 
9781636484167: Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway
Couverture souple
ISBN 10 : 1636484166 ISBN 13 : 9781636484167
Editeur : Eliva Press, 2021

Synopsis

Non-small cell lung cancer (NSCLC) is a prominent subtype of lung carcinoma that accounts for the majority of cancer-related deaths globally, and it is responsible for about 80% to 85% of lung cancers. Mitogen-Activated Protein Kinase (MAPK) signaling pathways are a vital aspect of NSCLC, and have aided in the advancement of therapies for this carcinoma. Targeting the Ras/Raf/MEK/ERK pathway is a promising and alternative method in NSCLC treatment, which is highlighted in this book. The introduction of targeted medicines has revolutionized the treatment of patients with this carcinoma. When combined with current systems biology-driven stratagems, repurposing non-cancer drugs into new therapeutic niches presents a cost-effective and efficient technique with enhancing outcomes for discovering novel pharmacological activity. This book also highlights the successful cutting-edge techniques while focusing on NSCLC targeted therapies. The ultimate challenge will be integrating these repurposed drugs into the therapeutic regimen of patients affected with NSCLC to potentially increase lung cancer cure rates.

Authors: Shiva Prasad Kollur, Anisha S Jain, Gayatri Vaidya, Poojitha B. Sridara Setty, Shivalingaiah, Ashwini Prasad, Ravindra Veerapur, Veena Malligere Ankegowda, Asad Syed, Ali. H Bhakali, Chandrashekar Srinivasa, Sharanagouda Patil, Chandan Shivamallu

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Éditeur
Eliva Press
Date d'édition
2021
Langue
anglais
ISBN 10 
1636484166
ISBN 13 
9781636484167
Reliure
Broché
Nombre de pages
49
Coordonnées du fabricant
non disponible
Personne responsable
non disponible